PuSH - Publication Server of Helmholtz Zentrum München

Tilch, K.* ; Hopff, S.M.* ; Appel, K.* ; Kraus, M. ; Lorenz-Depiereux, B. ; Pilgram, L.* ; Anton, G. ; Berger, S.* ; Geißler, R.* ; Haas, K.* ; Illig, T.* ; Krefting, D.* ; Lorbeer, R.* ; Mitrov, L.* ; Muenchhoff, M.* ; Nauck, M.* ; Pley, C.* ; Reese, J.P.* ; Rieg, S.* ; Scherer, M.* ; Stecher, M.* ; Stellbrink, C.* ; Valentin, H.* ; Winter, C.* ; Witzenrath, M.* ; Vehreschild, J.J.*

Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany.

BMC Med. Ethics 24:84 (2023)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
With the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), global researchers were confronted with major challenges. The German National Pandemic Cohort Network (NAPKON) was launched in fall 2020 to effectively leverage resources and bundle research activities in the fight against the coronavirus disease 2019 (COVID-19) pandemic. We analyzed the setup phase of NAPKON as an example for multicenter studies in Germany, highlighting challenges and optimization potential in connecting 59 university and nonuniversity study sites. We examined the ethics application process of 121 ethics submissions considering durations, annotations, and outcomes. Study site activation and recruitment processes were investigated and related to the incidence of SARS-CoV-2 infections. For all initial ethics applications, the median time to a positive ethics vote was less than two weeks and 30 of these study sites (65%) joined NAPKON within less than three weeks each. Electronic instead of postal ethics submission (9.5 days (Q1: 5.75, Q3: 17) vs. 14 days (Q1: 11, Q3: 26), p value = 0.01) and adoption of the primary ethics vote significantly accelerated the ethics application process. Each study center enrolled a median of 37 patients during the 14-month observation period, with large differences depending on the health sector. We found a positive correlation between recruitment performance and COVID-19 incidence as well as hospitalization incidence. Our analysis highlighted the challenges and opportunities of the federated system in Germany. Digital ethics application tools, adoption of a primary ethics vote and standardized formal requirements lead to harmonized and thus faster study initiation processes during a pandemic.
Impact Factor
Scopus SNIP
Altmetric
2.700
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Covid-19 ; Ethical Approval ; Ethics Committee ; Multicenter Study ; Pandemic Preparedness ; Study Initiation; Requirements; Conduct; Consent
Language english
Publication Year 2023
HGF-reported in Year 2023
e-ISSN 1472-6939
Quellenangaben Volume: 24, Issue: 1, Pages: , Article Number: 84 Supplement: ,
Publisher BioMed Central
Publishing Place Campus, 4 Crinan St, London N1 9xw, England
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
POF-Topic(s) 30202 - Environmental Health
Research field(s) Genetics and Epidemiology
PSP Element(s) G-504091-004
Grants University Hospital LMU Munich
We gratefully thank all NAPKON sites for their recruitment. The representatives of the top three SUEP and HAP NAPKON sites are (alphabetical order): Bielefeld University, Medical School and University Medical Center East Westphalia-Lippe, Bielefeld, East
Scopus ID 85174457196
PubMed ID 37848886
Erfassungsdatum 2023-11-28